Antidiabetic effect of the root ethanolic extract of burdock (Arctium lappa L.), a traditional medicinal and edible plant, was investigated in streptozotocin- induced diabetic rats. The results show that the oral administration of burdock root ethanolic extract (BRE) significantly decreased blood glucose and increased insulin level in diabetic rats compared to the control diabetic group. Meanwhile, the levels of serum total cholesterol (TC), triglycerides (TG) and low density lipoprotein (LDL) in the BRE treated diabetic rats were lower, and the high density lipoprotein (HDL) level was higher than those index of the control diabetic rats. Furthermore, oral administration of BRE significantly decreased serum urea and creatinine as well as malondialdehyde (MDA) levels of liver and kidney tissues, while body weight gain and tissue glycogen content were elevated in diabetic rat, all of which indicate an improvement in diabetic state. In addition, 400 mg/kg body weight BRE treated group had a marked improvement of the glucose tolerance in normoglycemic rats. No hypoglycemic effects of BRE were observed in normal rats. The results demonstrate that BREpossessed significant antidiabetic activity in diabetic rats.
Key words: Burdock root, ethanolic extract, antidiabetic effect.
STZ, Streptozotocin; BRE, burdock root ethanolic extract; b.w, body weight; HDL, high density lipoprotein; LDL, low density lipoprotein; MDA,malondialdehyde.
Copyright © 2021 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0